New Release | White Paper of the GAPL 2 Project: Enhancing Sustainability in Tertiary Packaging for Pharma Air Cargo
Pharma.Aero has released the White Paper showcasing the findings of the sustainability project focusing on the tertiary packaging in the pharmaceutical air cargo. Aimed at advancing the sustainability of tertiary packaging in pharmaceutical air cargo, the project is the result of a broad global collaboration, incorporating insights from 160+ manufacturers, logistics providers, airports, and other key stakeholders across the supply chain.
Read here the Pharma.Aero Security Standards_White Paper
Pharma.Aero launched GAPL 2, the second phase of its Green Air Pharma Logistics initiative, to improve the sustainability of tertiary packaging used in transporting temperature-sensitive pharmaceuticals. Building on GAPL 1, which introduced the Lane Sustainability Readiness Index (LSRI), this phase focused on developing a comprehensive assessment framework through collaboration with over 160 stakeholders. The framework evaluates packaging solutions based on environmental criteria like carbon footprint, water use, reusability, and recyclability, and integrates with the LSRI to guide industry decisions. GAPL 2 emphasizes that sustainable packaging is a shared responsibility and a critical step toward reducing emissions and advancing circular, climate-conscious logistics.
Key Highlights of the White Paper:
– 𝐏𝐚𝐜𝐤𝐚𝐠𝐢𝐧𝐠 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 & 𝐒𝐦𝐚𝐫𝐭 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬
– 𝐂𝐢𝐫𝐜𝐮𝐥𝐚𝐫 𝐄𝐜𝐨𝐧𝐨𝐦𝐲 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬
– 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐂𝐫𝐢𝐭𝐞𝐫𝐢𝐚 & 𝐀𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭 𝐈𝐧𝐝𝐢𝐜𝐚𝐭𝐨𝐫𝐬
– 𝐂𝐫𝐨𝐬𝐬-𝐕𝐚𝐥𝐮𝐞 𝐂𝐡𝐚𝐢𝐧 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧
This project brought together 160+ global stakeholders across the pharmaceutical logistics ecosystem to co-create practical solutions and frameworks that advance climate goals, reduce waste, and improve packaging sustainability. Pharma.Aero invites stakeholders across the industry to engage with this research and join efforts to enhance security standards. The full white paper is now available for download on www.pharma.aero.
We sincerely thank all our members and partners who generously participated in this project’s workshops, interviews and survey—your shared insights and expertise were instrumental in shaping the depth, relevance, and impact of this project.
For Pharma.Aero members only, check the GAPL 2 Technical Report in the Member Area of our website.
Are you a Pharma.Aero member, but have not registered yet? Learn how to create a personal account and access the exclusive content for members here.